title: Carcinoid syndrome.
abstract: Carcinoid tumors stimulate the release of specific hormones that lead to flushing, diarrhea, and bronchospasm. Serotonin is the most significant of these substances. Recently, a somatostatin analogue as well as the longer acting octreotide have been used to inhibit tumor secretions and reduce their untoward actions. This is a case report in which somatostatin was used perioperatively for removal of carcinoid tumors with an uneventful course.
authors.forename: J K
authors.initials: JK
authors.lastname: Zambrzycki
authors.forename: C G
authors.initials: CG
authors.lastname: Elliott
mesh_terms: D002276:Carcinoid Tumor / Q000188:drug therapy* / Q000503:physiopathology / Q000556:secondary / Q000601:surgery*; D003131:Combined Modality Therapy; D006801:Humans; D007414:Intestinal Neoplasms / Q000473:pathology*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D013004:Somatostatin / Q000627:therapeutic use*
chemical_list: D013004:Somatostatin